We use cookies to improve your experience and optimize user-friendliness. Read our cookie policy for more information on the cookies we use and how to delete or block them. To continue browsing our site, please click accept.

Life Science Emerging Growth Companies: Accounting for Your Funding

Presented by Withum & Jameson & Co.

Series A, SBIR/STTR, R01, BARDA, Venture Capital, Private Equity, SBA Loans, Private Investors – whatever way you choose to fund your business comes with specific accounting requirements. From negotiating indirect rates with the government to preparing quarterly financials and negotiating term sheets, you must understand your financial reporting obligations so your business can grow successfully and without penalty.

Register Here

 

Event Details
We are offering this event at two separate locations. Please select the date that best fits your availability.
January 30, 2020
11:30 AM – 1:00 PMMassBio
300 Technology Square, Suite 8
Cambridge, MA 02139
January 31, 2020
10:00 AM – 11:00 AMUMass M2D2
110 Canal Street, 4th Floor
Lowell, MA 01852
 

Session Overviews

Cambridge Event at MassBio
Speakers: Taryn Bostjancic, CPA and Life Science Practice Leader at Withum, Brian LaCroix, CPA and Partner of Jameson & Co. LLC, Will Adams, CEO of Riparian Pharmaceuticals and David Raiser, CEO of Aldatu BioSciences

  • Discuss the ins and outs of accounting for emerging growth companies based on their current funding and future funding goals
  • First hand accounts from CEOs while they continue to build their businesses, specifically in the life science industry

Lowell Event at UMass M2D2
Speakers: Taryn Bostjancic, CPA and Life Science Practice Leader at Withum and Brian LaCroix, CPA and Partner of Jameson & Co. LLC

  • Discuss the ins and outs of accounting for emerging growth companies based on their current funding and future funding goals.

 

Get news updates and event information from Withum

Subscribe